X4 Pharmaceuticals, Inc.
ANTI-RESPIRATORY SYNCYTIAL VIRUS ANTIBODIES, AND METHODS OF THEIR GENERATION AND USE
Last updated:
Abstract:
Anti-RSV antibodies with neutralizing potency against RSV subtype A and RSV subtype B are provided, as well as methods for their identification, isolation, generation, and methods for their preparation and use are provided.
Status:
Application
Type:
Utility
Filling date:
20 Oct 2017
Issue date:
16 Jul 2020